Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 83.37% is in line with its 5-year average of 82.73%, near the high end of its 5-year range (60.03%–88.08%).
1.80% above its 12-month average of 81.90%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 77.53%.
GROSS MARGIN
83.37%
GROSS MARGIN AVG TTM
81.90%
GROSS MARGIN AVG 3Y
83.08%
GROSS MARGIN AVG 5Y
82.73%
GROSS MARGIN AVG 10Y
81.90%
GROSS MARGIN AVG 15Y
83.24%
GROSS MARGIN AVG 20Y
84.88%
CURRENT VS TTM AVG
+1.80%
CURRENT VS 3Y AVG
+0.35%
CURRENT VS 5Y AVG
+0.78%
CURRENT VS 10Y AVG
+1.79%
CURRENT VS 15Y AVG
+0.15%
CURRENT VS 20Y AVG
-1.78%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+101.47%
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$106.98M
Gross Margin
83.37%
TTM Avg
81.90%
3Y Avg
83.08%
5Y Avg
82.73%
Market Cap
$106.91M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.35%
Market Cap
$108.59M
Gross Margin
46.49%
TTM Avg
23.25%
3Y Avg
11.62%
5Y Avg
7.75%
Market Cap
$108.66M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$108.33M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$105.07M
Gross Margin
71.67%
TTM Avg
77.09%
3Y Avg
79.04%
5Y Avg
77.65%
Market Cap
$105.15M
Gross Margin
99.54%
TTM Avg
49.77%
3Y Avg
24.89%
5Y Avg
16.59%
Market Cap
$103.60M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
5.83%
5Y Avg
8.02%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $106.98M | 83.37% | 81.90% | 83.08% | 82.73% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | 0.00% | 0.00% | 0.00% | 2.35% |
| Immunic, Inc. (IMUX)vs › | $107.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.59M | 46.49% | 23.25% | 11.62% | 7.75% |
| Vivani Medical, Inc. (VANI)vs › | $108.66M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Definitive Healthcare Corp. (DH)vs › | $105.07M | 71.67% | 77.09% | 79.04% | 77.65% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $105.15M | 99.54% | 49.77% | 24.89% | 16.59% |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.60M | 0.00% | 0.00% | 5.83% | 8.02% |
| Apyx Medical Corporation (APYX)vs › | $109.91M | 33.94% | 48.53% | 56.75% | 59.91% |
Gross Margin
83.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 77.53% |
| 2026-03-31 | 78.82% |
| 2025-12-31 | 83.61% |
| 2025-09-30 | 88.08% |
| 2025-06-30 | 81.44% |
| 2025-03-31 | 87.83% |
| 2024-12-31 | 81.06% |
| 2024-09-30 | 85.44% |
| 2024-06-30 | 82.63% |
| 2024-03-31 | 81.46% |
| 2023-12-31 | 83.64% |
| 2023-09-30 | 82.49% |
| 2023-06-30 | 86.03% |
| 2023-03-31 | 86.45% |
| 2022-12-31 | 70.95% |
| 2022-09-30 | 80.51% |
| 2022-06-30 | 80.27% |
| 2022-03-31 | 80.21% |
| 2021-12-31 | 60.03% |
| 2021-09-30 | 83.55% |
| 2021-06-30 | 80.78% |
| 2021-03-31 | 77.06% |
| 2020-12-31 | 77.92% |
| 2020-09-30 | 76.84% |
| 2020-06-30 | 72.81% |
| 2020-03-31 | 80.38% |
| 2019-12-31 | 79.40% |
| 2019-09-30 | 81.47% |
| 2019-06-30 | 82.62% |
| 2019-03-31 | 83.20% |
| 2018-12-31 | 78.76% |
| 2018-09-30 | 82.80% |
| 2018-06-30 | 85.01% |
| 2018-03-31 | 82.21% |
| 2017-12-31 | 81.51% |
| 2017-09-30 | 80.65% |
| 2017-06-30 | 80.74% |
| 2017-03-31 | 85.66% |
| 2016-12-31 | 82.32% |
| 2016-09-30 | 77.55% |
| 2016-06-30 | 84.42% |
| 2016-03-31 | 84.18% |
| 2015-12-31 | 80.23% |
| 2015-09-30 | 87.57% |
| 2015-06-30 | 86.12% |
| 2015-03-31 | 86.63% |
| 2014-12-31 | 85.41% |
| 2014-09-30 | 86.23% |
| 2014-06-30 | 86.68% |
| 2014-03-31 | 86.98% |
| 2013-12-31 | 73.71% |
| 2013-09-30 | 84.21% |
| 2013-06-30 | 83.69% |
| 2013-03-31 | 89.19% |
| 2012-12-31 | 84.14% |
| 2012-09-30 | 92.64% |
| 2012-06-30 | 91.08% |
| 2012-03-31 | 91.73% |
| 2011-12-31 | 85.03% |
| 2011-09-30 | 89.73% |
| 2011-06-30 | 91.08% |
| 2011-03-31 | 92.62% |
| 2010-12-31 | 92.55% |
| 2010-09-30 | 92.54% |
| 2010-06-30 | 91.96% |
| 2010-03-31 | 91.52% |
| 2009-12-31 | 91.93% |
| 2009-09-30 | 87.05% |
| 2009-06-30 | 92.09% |
| 2009-03-31 | 92.20% |
| 2008-12-31 | 91.67% |
| 2008-09-30 | 91.45% |
| 2008-06-30 | 91.18% |
| 2008-03-31 | 90.90% |
| 2007-12-31 | 89.78% |
| 2007-09-30 | 90.61% |
| 2007-06-30 | 91.20% |
| 2007-03-31 | 90.33% |
| 2006-12-31 | 84.36% |
| 2006-09-30 | 86.72% |
| 2006-06-30 | 85.69% |
| 2006-03-31 | 98.04% |
